NCT00819507View on ClinicalTrials.gov

VANOS Cream and Skin Barrier Function

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

June 21, 2010

Conditions
Atopic Dermatitis
Interventions
DRUG

Fluocinonide

Fluocinonide 0.1% cream topical daily for two weeks

Trial Locations (1)

97239

Oregon Health & Science University Department of Dermatology, Portland

Sponsors
All Listed Sponsors
collaborator

Medicis Pharmaceutical Corporation

INDUSTRY

lead

Oregon Health and Science University

OTHER